Stocktoria

LEMAITRE VASCULAR INC LMAT

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2006-10-19 · LEI

LEMAITRE VASCULAR INC statistics & valuation

P / E37.9×
P / S8.8×
P / B5.6×
Net margin23.1%
Return on capital11.7%
Graham number -62%$31.19

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($31.19); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
11.90% 17.00% 21.70% 15.30% 16.40% 17.40% 12.80% 15.60% 20.00% 23.10% 2016201720182019202020212022202320242025
Gross margin (%)
70.60% 70.10% 70.00% 68.10% 65.40% 65.70% 64.90% 65.70% 68.60% 71.50% 2016201720182019202020212022202320242025
Operating margin (%)
18.30% 20.90% 26.70% 18.10% 22.30% 23.60% 16.60% 19.00% 23.80% 27.20% 2016201720182019202020212022202320242025
Return on equity (%)
12.10% 15.60% 17.60% 12.10% 12.30% 10.60% 7.70% 10.10% 13.10% 14.70% 2016201720182019202020212022202320242025
Shares outstanding
19.2M 20.0M 20.2M 20.3M 20.5M 21.5M 22.2M 22.4M 22.8M 22.9M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
10.40% 13.60% 15.00% 9.50% 8.40% 9.20% 6.60% 8.70% 8.00% 9.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
15.80% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
$0.55 $0.86 $1.13 $0.88 $1.04 $1.25 $0.93 $1.34 $1.93 $2.52 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

LEMAITRE VASCULAR INC trades at about 32.6× earnings — below its 10-year norm (10-year range 21.1×–50.7×, median 41.3×).

21.1× 50.7×

Shaded band = 10-year range (21.1×–50.7×); dot = today's 32.6×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin71.5%68.6%65.7%64.9%65.7%65.4%68.1%70.0%70.1%70.6%
Operating margin27.2%23.8%19.0%16.6%23.6%22.3%18.1%26.7%20.9%18.3%
Net margin23.1%20.0%15.6%12.8%17.4%16.4%15.3%21.7%17.0%11.9%
FCF margin15.8%
Return on assets9.4%8.0%8.7%6.6%9.2%8.4%9.5%15.0%13.6%10.4%
Return on equity14.7%13.1%10.1%7.7%10.6%12.3%12.1%17.6%15.6%12.1%
Current ratio12.8913.146.516.396.413.754.424.766.095.63

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.